Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Heart, Lung & Circulation|August 27, 2025
Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome ManagementGina Davis, Dana Kim, Min Jun, et al.
Lancet (London, England)|June 3, 2026
Advances in understanding the impact of sex on kidney health and diseaseJennifer S Lees, Kate I Stevens, Sradha S Kotwal, et al.
Internal Medicine Journal|May 22, 2019
Impact of supplemental private health insurance on dialysis and outcomesArunan Sriravindrarajah, Sradha S Kotwal, Shaundeep Sen, et al.
Nephrology (Carlton, Vic.)|July 30, 2013
Comparative efficacy of a team-led treatment protocol for the management of renal anaemiaSradha S Kotwal, Patrick Lan, Avril MacLeod, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 28, 2013
Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic reviewChristopher A Muir, Sradha S Kotwal, Carmel M Hawley, et al.
Diabetes, Obesity & Metabolism|January 21, 2026
Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice datasetHannah Wallace, Luke Buizen, Sunil V Badve, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 4, 2025
Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trialBryony Beal, Luke Buizen, Emily K Yeung, et al.
The Lancet Regional Health. Western Pacific|April 25, 2025
Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice datasetHannah Wallace, James Wick, Daniel Bekele Ketema, et al.
Kidney360|October 27, 2025
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice DatasetTakaya Sasaki, Luke Buizen, Katie Harris, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2026
Efficacy and Safety of Atrasentan in Patients with IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors: Placebo-Controlled, Crossover TrialHiddo J L Heerspink, Irene L Noronha, Jose Luis Górriz, et al.
Pageof 2